Noble Financial set a $19.00 price target on electroCore (NASDAQ:ECOR) in a research report released on Friday, TipRanks reports. The firm currently has a buy rating on the stock.
A number of other research analysts also recently weighed in on the stock. Cantor Fitzgerald lowered their price objective on shares of electroCore from $23.00 to $19.00 and set an overweight rating on the stock in a research report on Wednesday, May 15th. BTIG Research cut shares of electroCore from a buy rating to a neutral rating in a report on Wednesday, May 15th. Finally, Zacks Investment Research raised shares of electroCore from a sell rating to a hold rating in a report on Monday, May 13th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. electroCore presently has a consensus rating of Buy and a consensus price target of $20.25.
electroCore stock traded up $0.12 during midday trading on Friday, reaching $3.12. 180,115 shares of the company traded hands, compared to its average volume of 146,826. The company has a market cap of $88.89 million and a price-to-earnings ratio of -2.62. electroCore has a 12 month low of $2.82 and a 12 month high of $20.25. The company has a quick ratio of 10.00, a current ratio of 10.74 and a debt-to-equity ratio of 0.08.
electroCore (NASDAQ:ECOR) last issued its quarterly earnings data on Tuesday, May 14th. The company reported ($0.47) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.54) by $0.07. Sell-side analysts expect that electroCore will post -2.02 EPS for the current fiscal year.
In other electroCore news, insider Joseph P. Errico sold 10,408 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $6.97, for a total transaction of $72,543.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Joseph P. Errico sold 39,592 shares of the company’s stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $5.52, for a total transaction of $218,547.84. The disclosure for this sale can be found here.
Hedge funds and other institutional investors have recently made changes to their positions in the company. New York State Common Retirement Fund purchased a new stake in shares of electroCore in the fourth quarter worth $41,000. American International Group Inc. increased its stake in shares of electroCore by 95.3% in the first quarter. American International Group Inc. now owns 7,759 shares of the company’s stock worth $54,000 after purchasing an additional 3,787 shares in the last quarter. Wsfs Capital Management LLC purchased a new stake in shares of electroCore in the fourth quarter worth $63,000. Rhumbline Advisers purchased a new stake in shares of electroCore in the first quarter worth $73,000. Finally, Valeo Financial Advisors LLC purchased a new stake in shares of electroCore in the first quarter worth $90,000. 14.09% of the stock is owned by hedge funds and other institutional investors.
electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Further Reading: How To Calculate Debt-to-Equity Ratio
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.